News

The FDA designation is a step forward for Neuralink as owner Elon Musk faces increasing scrutiny. The US Food and Drug ...
CHENNAI: It’s nothing but the dance of mind and machine, where neurons whisper secrets and wires weave dreams. As the digital age revolutionises healthcare, it ...
The speech restoration device—an AI-driven brain ... Future Outlook: A New Frontier in Neurotechnology Neuralink's advancements in brain-computer interface technology represent a major leap ...
This marks China's first invasive BMI first-in-man clinical trial, making StairMed the second company globally, after Elon ...
Neuralink said on social media that it received FDA breakthrough device designation for treating individuals with severe ...
The US Food and Drug Administration (FDA) has awarded Neuralink’s brain-computer interface breakthrough device designation for the treatment of individuals with severe speech impairment.
Elon Musk announced plans to make Neuralink's brain-computer interface technology "widely available" following the company's ...
Brad Smith, of Arizona, has become the first person with ALS to receive a brain implant from Neuralink as part of an ongoing clinical trial.
Smith is the first non-verbal individual and only the third person globally to receive a Neuralink Brain-Chip Interface (BCI) implant.
The US Food and Drug Administration (FDA) has granted 'breakthrough device' status to Neuralink’s experimental speech ...
The Food and Drug Administration on Thursday cleared a core component of a brain implant made by Precision Neuroscience, a ...
Brad Smith is the third person in the world to get a brain chip implant with Elon Musk's Neuralink, and the first nonverbal ALS patient to do so.